Dynamics of cytokine profile indexes in children with first diagnosed pulmonary tuberculosis in the course of antimycobacterial therapy

Antimycobacterial therapy is the main method of tuberculosis treatment. But some antimycobacterial medications have an unfavorable influence on the immune system and this fact significantly decreases efficiency of treatment and requires an additional pathogenetic immunocorrection. The aim of the...

Full description

Bibliographic Details
Main Authors:	O. M. Raznatovska, Yu. V. Mironchuk
Format:	Article
Language:	English
Published:	Zaporozhye State Medical University 2018-04-01
Series:	Zaporožskij Medicinskij Žurnal
Subjects:	cytokines children tuberculosis treatment
Online Access:	http://zmj.zsmu.edu.ua/article/view/125171/124581

Similar Items

Cytokine profile in children with newly diagnosed tuberculosis
by: O. M. Raznatovska, et al.
Published: (2017-10-01)

The effect of immunomodulator azoximer bromide on the cytokine profile in a complex therapy for children with newly diagnosed tuberculosis
by: Yu. V. Mironchuk, et al.
Published: (2022-05-01)

Clinical and radiological characteristics of the course of the newly diagnosed tuberculosis spondylitis in adults and the effectiveness of the main course of antimycobacterial therapy
by: О. М. Raznatovska, et al.
Published: (2018-08-01)

The effect of immunomodulator azoximer bromide on immunoglobulin levels in children with newly diagnosed tuberculosis
by: O. M. Raznatovska, et al.
Published: (2022-08-01)

Pulmonary lesions in visceral toxocariasis in children in the phthisiatric practice (clinical case)
by: O.M. Raznatovska, et al.
Published: (2021-05-01)

Efficacy and safety of quercetin and polyvinylpyrrolidone in treatment of patients with newly diagnosed destructive pulmonary tuberculosis in comparison with standard antimycobacterial therapy
by: Dmytro Butov, et al.
Published: (2016-01-01)

Changes in the levels of adipokines in newly diagnosed pulmonary tuberculosis patients in case of treatment failure
by: R. M. Yasinskyi, et al.
Published: (2020-04-01)

Epidemiological and Cytokine Profile of Patients with Pulmonary and Extrapulmonary Tuberculosis in a Population of the Brazilian Amazon
by: Maria Alice Freitas Queiroz, et al.
Published: (2022-10-01)

The feasibility of immunocorrective therapy in the treatment of children with new tuberculosis cases
by: Yu. V. Myronchuk, et al.
Published: (2022-11-01)

Cytokine profile and efficacy of chemotherapy depending on thyroid state in patients with pulmonary tuberculosis.
by: S. L. Matvyeyeva, et al.
Published: (2018-04-01)

Clinical course features of newly diagnosed pulmonary tuberculosis treatment failure
by: R. M. Yasinskyi, et al.
Published: (2016-06-01)

Serum Cytokine Biomarkers for Use in Diagnosing Pulmonary Tuberculosis versus Chronic Pulmonary Aspergillosis
by: Ren W, et al.
Published: (2023-04-01)

Changes of the pro-hormone levels of vitamin D 25(OH)D in patients with newly diagnosed pulmonary tuberculosis treatment failure
by: R. M. Yasinskyi, et al.
Published: (2020-06-01)

Cytokine Receptors—Regulators of Antimycobacterial Immune Response
by: Magdalena Druszczyńska, et al.
Published: (2022-01-01)

Association of plasma cytokines with radiological recovery in pulmonary tuberculosis patients
by: Najeeha Talat Iqbal, et al.
Published: (2016-01-01)

Cytokine/chemokine profiles in people with recent infection by Mycobacterium tuberculosis
by: Mariana Herrera, et al.
Published: (2023-05-01)

CYTOKINES AS MARKERS OF THE INFILTRATIVE PULMONARY TUBERCULOSIS DEVELOPMENT
by: M. V. Mezentseva, et al.
Published: (2014-07-01)

Serum lymphocytes and cytokines: diagnostic value and influence on the immune status in patients with pulmonary tuberculosis
by: Zhiqiang Ma, et al.
Published: (2023-10-01)

Surgical treatment of pulmonary tuberculosis in children
by: M. S. Opanasenko, et al.
Published: (2019-10-01)

CORRELATIONS BETWEEN CLINICAL SEVERITY OF PULMONARY TUBERCULOSIS, THYROID FUNCTION AND SOME CYTOKINES
by: Svetlana MATVYEYEVA, et al.
Published: (2022-12-01)

Discovery and Validation of a Three-Cytokine Plasma Signature as a Biomarker for Diagnosis of Pediatric Tuberculosis
by: Nathella Pavan Kumar, et al.
Published: (2021-04-01)

Cytokine Biomarkers Associated with Human Extra-Pulmonary Tuberculosis Clinical Strains and Symptoms
by: Paulo Ranaivomanana, et al.
Published: (2018-02-01)

Antigen-Specific Cytokine and Chemokine Gene Expression for Diagnosing Latent and Active Tuberculosis
by: Workneh Korma, et al.
Published: (2020-09-01)

Bedaquiline resistance in Mycobacterium tuberculosis during antimycobacterial therapy and its impact on clinical outcomes (clinical cases)
by: O. M. Raznatovska, et al.
Published: (2023-03-01)

Low body mass index is associated with diminished plasma cytokines and chemokines in both active and latent tuberculosis
by: Nathella Pavan Kumar, et al.
Published: (2023-05-01)

Prevalence and treatment outcome of pulmonary and extra pulmonary pediatric tuberculosis in southwestern Iran
by: Seyed Mohammad Alavi, et al.
Published: (2015-10-01)

A Study of Serum Malondialdehyde and Cytokine in Tuberculosis Patients
by: Rashmi Kulkarni, et al.
Published: (2013-10-01)

Clinical features of the pulmonary tuberculosis course combined with different diabetes mellitus types in the Zaporizhzhia region
by: O. M. Raznatovska, et al.
Published: (2017-12-01)

THE PRODUCTION OF PRO-INFLAMMATORY CYTOKINES AND THE STATE OF CELLULAR IMMUNITY IN PATIENTS WITH PULMONARY TUBERCULOSIS WITH AND WITHOUT RELAPSE
by: Elena TUDOR, et al.
Published: (2022-12-01)

DIAGNOSTICS, CLINICAL COURSE AND EFFECTIVENESS OF TREATMENT OF NEWLY DIAGNOSED YOUNG PATIENTS WITH RESPIRATORY TUBERCULOSIS
by: I. A. Morozov, et al.
Published: (2017-04-01)

Topicality of the problem of combined course of multi-drug resistant pulmonary tuberculosis with diabetes mellitus
by: O. M. Raznatovska, et al.
Published: (2017-08-01)

Efficacy and safety of quercetin and polyvinylpyrrolidone in treatment of patients with newly diagnosed destructive pulmonary tuberculosis in comparison with standard antimycobacterial therapy
by: Dmytro Butov, et al.
Published: (2016-01-01)

Cytokine Biosignature of Active and Latent Mycobacterium Tuberculosis Infection in Children
by: Magdalena Druszczynska, et al.
Published: (2021-04-01)

Levels of vitamin D-associated cytokines distinguish between active and latent tuberculosis following a tuberculosis outbreak
by: Yoonki Hong, et al.
Published: (2019-02-01)

Clinical manifestations and outcomes of tuberculosis in children in the Irkutsk region
by: S. G. Zvonkova, et al.
Published: (2016-04-01)

Effect of Curcumin in Experimental Pulmonary Tuberculosis: Antimycobacterial Activity in the Lungs and Anti-Inflammatory Effect in the Brain
by: Jacqueline V. Lara-Espinosa, et al.
Published: (2022-02-01)

Features of pregnancy course in women with chemoresistant tuberculosis (a literature review)
by: O. M. Raznatovska, et al.
Published: (2019-10-01)

The evolution of the cytokine profile under the influence of immunomodulator glutamine-cystine-glycine disodium in patients with destructive multidrug-resistant lung tuberculosis
by: E. N. Raznatovskaya
Published: (2015-06-01)

Methodology of the Treatment of Pulmonary Tuberculosis
by: Frayt V., et al.
Published: (2013-03-01)

The course of multidrug-resistant pulmonary tuberculosis in HIV-infected people with COVID-19
by: O. M. Raznatovska, et al.
Published: (2022-09-01)